Welcome to our dedicated page for Eltek SEC filings (Ticker: ELTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Eltek Ltd (NASDAQ: ELTK) files annual and interim reports with the U.S. Securities and Exchange Commission as a foreign private issuer under Form 20-F and Form 6-K. This SEC filings page aggregates those documents so investors can follow the company’s official financial and corporate disclosures alongside AI-generated summaries.
Eltek’s Form 20-F annual report includes audited consolidated financial statements, detailed notes, and discussions of its business as a global manufacturer and supplier of technologically advanced printed circuit boards (PCBs). The company also files multiple Form 6-K reports during the year, which, as disclosed in recent filings, furnish press releases on quarterly financial results, interim condensed consolidated financial statements, management’s discussion and analysis, notices and results of shareholder meetings, purchase order announcements and dividend declarations.
Through these filings, readers can track Eltek’s revenues, profitability, cash flows, investment program for new equipment and production lines, and information about its role as an Israeli leading company in the high-end PCB industry. The filings also describe its customer base in defense, aerospace and medical markets, its global footprint, and its use of non-GAAP measures such as EBITDA.
Stock Titan’s tools present Eltek’s SEC filings with AI-powered highlights that help explain the structure and key points of lengthy documents, such as annual reports and interim financial statements. Users can quickly identify major trends, important risk disclosures and significant corporate actions without reading every line. Real-time updates from EDGAR ensure that new Form 6-K and Form 20-F submissions, as well as other relevant filings, appear promptly, giving ELTK investors a structured view of the company’s regulatory record.
Eltek Ltd VP Sales and Marketing Tomer Segev filed an initial Form 3 reporting holdings of employee stock options. He holds options linked to 20,000 ordinary shares with a $10.51 exercise price expiring on November 18, 2034, granted on November 18, 2024, and options linked to 6,000 ordinary shares with a $8.82 exercise price expiring on March 8, 2036, granted on March 8, 2026. Both grants vest over four years, with 25% vesting after one year and 6.25% at the end of each following quarter.
Eltek Ltd director Dovev Gad has reported existing equity awards through a Form 3 filing. He holds employee stock options over 20,000 ordinary shares with an exercise price of $5.89 per share, expiring on September 6, 2031.
He also holds options over 10,000 ordinary shares with an exercise price of $8.67 per share, expiring on October 6, 2033. Footnotes state each grant vests over four years, with 25% vesting after one year from the grant date and 6.25% at the end of each following quarter.
Eltek Ltd Chief Executive Officer Eli Yaffe filed an initial Form 3 that lists his existing equity position in the company. He holds employee stock options over 8,480 ordinary shares at an exercise price of $3.59 expiring on November 14, 2028, 21,308 shares at $4.17 expiring on December 29, 2030, 25,000 shares at $8.70 expiring on August 3, 2033, and 20,000 shares at $15.83 expiring on March 10, 2034.
The option agreements provide four-year vesting, with 25% exercisable on the first anniversary of the grant date and an additional 6.25% at the end of each subsequent quarter. Yaffe also directly holds 7,250 ordinary shares, giving him a mix of current ownership and long-dated equity incentives.
Eltek Ltd. director David Rubner filed an initial ownership report showing stock option holdings. He holds employee stock options over 10,000 ordinary shares at an exercise price of $5.89 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.67 per share expiring on October 6, 2033. Footnotes state each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and 6.25% at the end of each following quarter, for grants dated September 6, 2021 and October 10, 2023.
Eltek Ltd. reported higher 2025 revenue but sharply lower profit as it upgraded and relocated manufacturing to support new plating lines. Full-year revenue rose to $51.8M from $46.5M, yet gross margin fell to 15% and operating income dropped to $2.3M from $4.4M.
Net income declined to $0.8M or $0.12 per diluted share, compared with $4.2M or $0.63 in 2024, hurt by operational disruption, workforce challenges and a weaker U.S. dollar versus the Israeli shekel that added about $2.2M to shekel-based expenses.
In the fourth quarter, revenue increased to $13.2M, but Eltek posted a net loss of $0.3M as gross margin compressed. EBITDA for 2025 was $4.5M (9% of revenue) versus $5.9M (13%) a year earlier. Management frames the heavy capital spending and modernization as positioning the company for long-term growth in defense and medical PCB markets.
Eltek Ltd. filed a Form 6-K to share details about its upcoming earnings release and conference call. The company will publish financial results for the fourth quarter and year ended December 31, 2025 before the market opens on March 9, 2026.
On March 9, 2026 at 9:30 a.m. Eastern Time, Eltek will host a conference call featuring CEO Eli Yaffe and CFO Ron Freund to discuss these results. The release and a replay of the call will be available through the Investor Info section of Eltek’s website.
Eltek Ltd. reported new purchase orders totaling $12.2 million from an American defense customer. The printed circuit board products covered by these orders are scheduled for delivery throughout 2026 and 2027 and will be used in a defense project.
The company highlighted that this win supports its strategic goal of expanding its presence in the U.S. market with high value-added products. Eltek positions itself as a global provider of advanced, complex PCBs serving defense, aerospace and medical customers across multiple regions.
Eltek Ltd. submitted a Form 6-K as a foreign private issuer for November 2025. The company explains that on November 18, 2025 it issued a press release reporting its third quarter 2025 financial results, and that this press release is attached to the submission as Exhibit 99.1.
Eltek Ltd. (ELTK) furnished a Form 6-K stating it issued a press release announcing its earnings release date and conference call. The press release is attached as Exhibit 99.1. This is an administrative update that informs the market about the timing and access details for the company’s upcoming earnings communications.
Eltek Ltd. reports the results of its Annual General Meeting of shareholders held on September 18, 2025. The company states that all resolutions described in the proxy statement furnished on Form 6-K on August 14, 2025 were duly adopted at the meeting. Shareholders therefore approved every item that was brought to a vote as outlined in that proxy statement. For the specific wording and details of each resolution, investors are directed to review the previously furnished Proxy Statement.